Hydrolytic Lysosomal Glucocerebroside-specific Enzyme class drugs
3 results
Cerezyme (imiglucerase)
(IMIGLUCERASE)Genzyme Corporation
Usage: Cerezyme is indicated for the treatment of adults and pediatric patients aged 2 years and older with Type 1 Gaucher disease, addressing conditions such as anemia, thrombocytopenia, bone disease, and hepatomegaly or splenomegaly.
Elelyso (taliglucerase alfa)
(Taliglucerase alfa)Pfizer Laboratories Div Pfizer Inc
Usage: ELELYSO is indicated for the treatment of Type 1 Gaucher disease in patients aged 4 years and older with a confirmed diagnosis.
Vpriv (velaglucerase alfa)
(velaglucerase alfa)Takeda Pharmaceuticals America, Inc.
Usage: VPRIV is indicated for long-term enzyme replacement therapy (ERT) in patients with type 1 Gaucher disease.